Sort   by:  
 Page size 
UnknownPhase III open-label randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline and a taxane.
Not available
S-EPMC4463422 | biostudies-literature
UnknownSequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancer.
Not available
S-EPMC3236650 | biostudies-literature
UnknownFour-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31.
Not available
S-EPMC3164242 | biostudies-literature
UnknownImpact of PTEN protein expression on benefit from adjuvant trastuzumab in early-stage human epidermal growth factor receptor 2-positive breast cancer in the North Central Cancer Treatment Group N9831 trial.
Not available
S-EPMC3731983 | biostudies-literature
UnknownOlaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.
Not available
S-EPMC6057749 | biostudies-literature
UnknownSafety and clinical activity of a combination therapy comprising two antibody-based targeting agents for the treatment of non-Hodgkin lymphoma: results of a phase I/II study evaluating the immunoconjugate inotuzumab ozogamicin with rituximab.
Not available
S-EPMC4878046 | biostudies-literature
UnknownEfficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy.
Not available
S-EPMC4992984 | biostudies-literature
UnknownDaratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX.
Not available
S-EPMC7643179 | biostudies-literature
UnknownThe Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy.
Not available
S-EPMC9977414 | biostudies-literature
UnknownDaratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX.
Not available
S-EPMC6269302 | biostudies-literature
Sort   by:  
 Page size